We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-7.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.17B
AUM Growth
-$939M
Cap. Flow
-$328M
Cap. Flow %
-6.34%
Top 10 Hldgs %
49.51%
Holding
202
New
57
Increased
36
Reduced
26
Closed
61

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$121M
2
PTCT icon
PTC Therapeutics
PTCT
+$81.6M
3
VTRS icon
Viatris
VTRS
+$76.4M
4
TGT icon
Target
TGT
+$69.6M
5
FIVE icon
Five Below
FIVE
+$60.3M

Top Sells

Rank Stock Value
1
ASO icon
Academy Sports + Outdoors
ASO
+$66.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$62.3M
3
ULTA icon
Ulta Beauty
ULTA
+$62.1M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$59.8M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$58.9M

Sector Composition

Rank Sector Weight
1 Healthcare 45.3%
2 Consumer Staples 9.22%
3 Consumer Discretionary 6.86%
4 Technology 3.5%
5 Communication Services 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BUD icon
26
AB InBev
BUD
$167B
$58.7M 1.14%
978,000
+442,000
+82% +$27.3M
REGN icon
27
Regeneron Pharmaceuticals
REGN
$78.3B
$58.7M 1.13%
84,000
-32,000
-28% -$20.2M
FIVE icon
28
Five Below
FIVE
$12.3B
$57.3M 1.11%
+361,745
New +$60.3M
DCPH
29
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$54.1M 1.05%
5,836,000
+2,405,846
+70% +$20.5M
MDT icon
30
Medtronic
MDT
$110B
$51.9M 1%
468,000
-244,000
-34% -$25.8M
CL icon
31
Colgate-Palmolive
CL
$73.8B
$48.2M 0.93%
636,000
+368,000
+137% +$29.1M
ALKS icon
32
Alkermes
ALKS
$8.33B
$48M 0.93%
1,824,000
-1,348,000
-42% -$33.4M
AZO icon
33
AutoZone
AZO
$49.4B
$46M 0.89%
22,481
-15,543
-41% -$30.4M
WMT icon
34
Walmart Inc
WMT
$888B
$44.8M 0.87%
902,682
-809,172
-47% -$38M
UBER icon
35
Uber
UBER
$147B
$44.1M 0.85%
1,236,000
+36,000
+3% +$1.29M
MGNX icon
36
MacroGenics
MGNX
$248M
$44M 0.85%
5,000,000
+2,300,000
+85% +$25.4M
POST icon
37
Post Holdings
POST
$4.11B
$44M 0.85%
636,000
+92,032
+17% +$6.44M
GOOGL icon
38
Alphabet (Google) Class A
GOOGL
$4.62T
$41.7M 0.81%
300,000
+60,000
+25% +$8.15M
PCRX icon
39
Pacira BioSciences
PCRX
$1.09B
$40M 0.77%
524,000
-788,000
-60% -$52.5M
AZN icon
40
AstraZeneca
AZN
$241B
$39.3M 0.76%
296,000
+96,000
+48% +$11.5M
ZYME icon
41
Zymeworks
ZYME
$1.68B
$37.7M 0.73%
5,760,000
+4,509,803
+361% +$40.2M
MSFT icon
42
Microsoft
MSFT
$3.66T
$37M 0.72%
120,000
+22,000
+22% +$6.62M
ADBE icon
43
Adobe
ADBE
$102B
$36.5M 0.7%
+80,000
New +$38.5M
ENR icon
44
Energizer
ENR
$1.48B
$35.3M 0.68%
1,148,000
-224,000
-16% -$7.79M
AVTX icon
45
Avalo Therapeutics
AVTX
$980M
$34.5M 0.67%
16,519
+894
+6% +$2.25M
TSVT
46
DELISTED
2seventy bio
TSVT
$34.1M 0.66%
2,000,000
+1,144,000
+134% +$19.4M
FMTX
47
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$29.8M 0.58%
3,200,000
+1,344,000
+72% +$14.3M
TOST icon
48
Toast
TOST
$19.6B
$28.8M 0.56%
+1,324,000
New +$29.9M
TMO icon
49
Thermo Fisher Scientific
TMO
$209B
$26.6M 0.51%
45,000
+21,000
+88% +$12.1M
DECK icon
50
Deckers Outdoor
DECK
$13.6B
$25.9M 0.5%
568,212
+238,002
+72% +$11.8M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Armistice Capital held 202 positions worth $5.17B, down 15% from $6.11B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital withdrew a net $328M in Q1 2022, closing 61 positions and reducing 26 holdings. Its most notable exit was Academy Sports + Outdoors, an estimated $66.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in Home Depot worth $105M.

  • Armistice Capital's largest Q1 2022 buy was Home Depot: 349,897 shares worth $105M.
  • Armistice Capital added most to PTC Therapeutics in Q1 2022, an estimated $81.6M increase.
  • Armistice Capital's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $62.3M.
  • Armistice Capital fully exited Academy Sports + Outdoors in Q1 2022, selling an estimated $66.3M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.17B portfolio in Q1 2022.
  • Armistice Capital opened 57 new positions and closed 61 in Q1 2022.
  • Armistice Capital's portfolio value fell 15% quarter-over-quarter to $5.17B.

Based on Armistice Capital's 13F filing for Q1 2022, filed 16 May 2022.